top of page

Evaluation of person-level heterogeneity of treatment effects in multiperson N-of-1 studies

  • Jan 31, 2019
  • 1 min read

Updated: Aug 2, 2023


Full title: Evaluation of person-level heterogeneity of treatment effects in published multiperson N-of-1 studies: systematic review and reanalysis


Authors: Raman, G., Balk, E. M., Lai, L., Shi, J., Chan, J., Lutz, J. S., ... & Kent, D. M. (2018)


This systematic review and reanalysis of 62 multi-person N-of-1 studies found identified statistically significant person-level heterogeneity of treatment effects in 8 of the 13 studies (62%) reporting person-level treatment effects and in 8 of the 14 studies (57%) reporting person-level outcomes. The authors concluded that person-level heterogeneity

of treatment effects is common and often substantial and called for improved assessment and reporting of person-level treatment effects in multi-person N-of-1 studies.


Click here to view the full article.


Full Citation: Raman, G., Balk, E. M., Lai, L., Shi, J., Chan, J., Lutz, J. S., ... & Kent, D. M. (2018). Evaluation of person-level heterogeneity of treatment effects in published multiperson N-of-1 studies: systematic review and reanalysis. BMJ open, 8(5), e017641. http://dx.doi.org/10.1136/bmjopen-2017-017641

 
 
 

Comments


ICN logo_edited_edited.png

A global community advancing the science and application of N-of-1 trials and single-case designs

Quick Links

> About

> Resources

> Events

> News

> Blog

> Articles

Contact us

  • Linkedin

Provide website feedback here

Membership

Open to researchers, clinicians, and healthcare consumers who support the ICN mission and vision. 

Copyright © 2018-2026 International Collaborative Network for N-of-1 Trials and Single-Case Designs | Privacy Statement 

bottom of page